Reductions also seen in comorbid anxiety and depression symptomsBURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a ...
The therapy module allows the system to be used for the treatment of major depression and chronic neuropathic pain as CE-marked ... Nexstim has developed a world-leading non-invasive brain stimulation ...